Age- and Gender-Specific Asthma Death Rates in Patients Taking Long-Acting -Agonists: Prescription Event Monitoring Pharmacosurveillance Studies

Author： Martin R.M.

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.6, 2001-01, pp. : 475-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting 2-adrenoceptor agonists: increased risk of death?

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

By Kim Dennis Glaum Mark Lockey Richard

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting β2-Agonists in Asthma: Not so SMART?

By Currie Graeme P.

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 647-656

Adis International

Access to resources Recommend Favorite

Long-Acting 2-Adrenoceptor Agonists and Exercise-Induced Asthma: Lessons to Guide Us in the Future

By Anderson Sandra D. Brannan John D.

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 161-175

Adis International

Access to resources Recommend Favorite